<?xml version="1.0" encoding="UTF-8"?>
<table id="PMC7871606/table_3" xmlns="http://www.w3.org/1999/xhtml">
 <caption>
  <label>Table 3</label>
  <p>Comparison of histological features of different study groups</p>
 </caption>
 <thead>
  <tr>
   <th colspan="1" rowspan="1" id="0-0-.">Groups</th>
   <th colspan="1" rowspan="1" id="0-1-.">Pathological finding</th>
  </tr>
 </thead>
 <tbody>
  <tr>
   <td>Control (CO)</td>
   <td>No cartilage degeneration; intact surface</td>
  </tr>
  <tr>
   <td>Osteoarthritis (OA)</td>
   <td>Severe cartilage degeneration (greater than 75% affected); formation of granulation tissue with neo vascularization; edema; infiltration of mononuclear leucocytes</td>
  </tr>
  <tr>
   <td>Osteoarthritis received gel contained the nanoemulsion (NG)</td>
   <td>Mild cartilage degeneration (11–25%); surface fibrillation; a few scattered lymphocytes; a very mild edema</td>
  </tr>
  <tr>
   <td>Osteoarthritis received the nanoemulsion solution (NS)</td>
   <td>Moderate cartilage degeneration (26–50%); moderate fibrillation; infiltration of mononuclear leucocytes</td>
  </tr>
  <tr>
   <td>Osteoarthritis received gel contained Mentha and Rosemary essential oils (EG)</td>
   <td>Marked cartilage degeneration (51–75%); neo vascularization; edema; infiltration of mononuclear leucocytes</td>
  </tr>
  <tr>
   <td>Osteoarthritis received gel contained 1% diclofenac sodium (DG)</td>
   <td>Mild cartilage degeneration (11–25%); surface fibrillation; a few scattered lymphocytes</td>
  </tr>
 </tbody>
</table>
